相关实验视频
Updated: Jun 30, 2025

Growth Assays to Assess Polyglutamine Toxicity in Yeast
Published on: March 5, 2012
多重氨酸乱:病原和潜在的药物干预.
Shweta Tandon1, Prerna Aggarwal1, Surajit Sarkar1
1Department of Genetics, University of Delhi South Campus, Benito Juarez Road, New Delhi 110021, India.
多重氨酸 (poly(Q)) 疾病是由扩大CAG重复引起的神经退行性疾病. 研究探索治疗点和化合物,以对抗这些相关疾病中的多重Q神经毒性.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 遗传学是一种遗传学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 多重氨酸 (poly(Q)) 疾病是九种遗传性神经退行性疾病的一组.
- 这些条件是由于特定基因的扩大CAG三核酸重复产生的.
- 致病性多种Q聚合物 (包括体) 损害细胞功能,导致疾病.
研究的目的:
- 审查多种疾病中的关键病原性事件.
- 讨论治疗干预的模型系统调查.
- 列出已被证明可以降低多Q介导神经毒性的化合物.
主要方法:
- 关于多重胺胺疾病病原学的文献综述.
- 对治疗目标的模型系统研究的分析.
- 关于神经保护性化合物的实验数据的汇编.
主要成果:
- 已确定受多 (Q) 聚合物影响的关键细胞通路.
- 突出了针对多元Q) 致病事件的潜力.
- 编制了一份药理学和生物活性化合物的清单,这些化合物的有效性已被证明.
结论:
- 多种Q型疾病具有共同的病因,允许跨疾病的治疗见解.
- 针对特定的致病事件提供了潜在的治疗策略.
- 各种化合物在缓解多Q介导的神经毒性方面表现有前途.
更多相关视频
08:16Caenorhabditis elegans as a Model System for Discovering Bioactive Compounds Against Polyglutamine-Mediated Neurotoxicity
Published on: September 21, 2021
06:49Monitoring Protein Aggregation Kinetics In Vivo using Automated Inclusion Counting in Caenorhabditis elegans
Published on: December 17, 2021
相关概念视频
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Parkinson's Disease: Overview
Lysosomal Hydrolases
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Alzheimer's Disease: Treatment
Antiepileptic Drugs: Glutamate Antagonists